» Articles » PMID: 34603530

Autophagy is Involved in Neurofibromatosis Type I Gene-modulated Osteogenic Differentiation in Human Bone Mesenchymal Stem Cells

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2021 Oct 4
PMID 34603530
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Neurofibromatosis type I (NF1) is an autosomal dominant genetic disease that is caused by mutations in the gene. Various studies have previously demonstrated that the mTOR complex 1 signaling pathway is essential for the -modulated osteogenic differentiation of bone mesenchymal stem cells (BMSCs). Additionally, the mTOR signaling pathway plays a notable role in autophagy. The present study hypothesized that could modulate the osteogenic differentiation of BMSCs by regulating the autophagic activities of BMSCs. In the present study, human BMSCs were cultured in an osteogenic induction medium. The expression of the gene was either knocked down or overexpressed by transfection with a specific small interfering RNA (siRNA) targeting or the pcDNA3.0 -overexpression plasmid, respectively. Autophagic activities of BMSCs (Beclin-1, P62, LC3B I, and LC3B II) were determined using western blotting, electron microscopy, acridine orange (AO) staining and autophagic flux/lysosomal detection by fluorescence microscopy. In addition, the autophagy activator rapamycin (RAPA) and inhibitor 3-methyladenine (3-MA) were used to investigate the effects of autophagy on -modulated osteogenic differentiation in BMSCs. Inhibiting with siRNA significantly decreased the expression levels of autophagy markers Beclin-1 and LC3B-II, in addition to osteogenic differentiation markers osterix, runt-related transcription factor 2 and alkaline phosphatase. By contrast, overexpressing with pcDNA3.0 significantly increased their levels. Transmission electron microscopy, AO staining and autophagic flux/lysosomal detection assays revealed that the extent of autophagosome formation was significantly decreased in the -siRNA group but significantly increased in the -pcDNA3.0 group when compared with the NC-siRNA and pcDNA3.0 groups, respectively. In addition, the activity of the PI3K/AKT/mTOR pathway [phosphorylated (p)-PI3K, p-AKT, p-mTOR and p-p70S6 kinase] was significantly upregulated in the -siRNA group compared with the NC-siRNA group, and significantly inhibited in the -pcDNA3.0 group, compared with the pcDNA3.0 group. The knockdown effects of -siRNA on the autophagy and osteogenic differentiation of BMSCs were reversed by the autophagy activator RAPA, while the overexpression effects of -pcDNA3.0 on the autophagy and osteogenic differentiation of BMSCs were reversed by the autophagy inhibitor 3-MA. In conclusion, results from the present study suggest at the involvement of autophagy in the -modulated osteogenic differentiation of BMSCs. Furthermore, may partially regulate the autophagic activity of BMSCs through the PI3K/AKT/mTOR signaling pathway.

Citing Articles

Anticancer potential of benzo[b]thiophene functionalized thiosemicarbazone ligands and their organoruthenium complexes.

Ozturk E, Subasi E, Kursunluoglu G, Yuksel B, Kayali H J Biol Inorg Chem. 2024; .

PMID: 39739051 DOI: 10.1007/s00775-024-02090-w.


Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.

Bouley S, Grassetti A, Allaway R, Wood M, Hou H, Burdon Dasbach I J Cell Sci. 2024; 137(15).

PMID: 39016685 PMC: 11361638. DOI: 10.1242/jcs.262343.


Current Aspects on the Pathophysiology of Bone Metabolic Defects during Progression of Scoliosis in Neurofibromatosis Type 1.

Kaspiris A, Savvidou O, Vasiliadis E, Hadjimichael A, Melissaridou D, Iliopoulou-Kosmadaki S J Clin Med. 2022; 11(2).

PMID: 35054138 PMC: 8781800. DOI: 10.3390/jcm11020444.

References
1.
Feldman D, Jordan C, Fonseca L . Orthopaedic manifestations of neurofibromatosis type 1. J Am Acad Orthop Surg. 2010; 18(6):346-57. DOI: 10.5435/00124635-201006000-00007. View

2.
Ferner R, Gutmann D . Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol. 2013; 115:939-55. DOI: 10.1016/B978-0-444-52902-2.00053-9. View

3.
Chang H, Li X, Cai Q, Li C, Tian L, Chen J . The PI3K/Akt/mTOR pathway is involved in CVB3-induced autophagy of HeLa cells. Int J Mol Med. 2017; 40(1):182-192. PMC: 5466389. DOI: 10.3892/ijmm.2017.3008. View

4.
Heras-Sandoval D, Perez-Rojas J, Hernandez-Damian J, Pedraza-Chaverri J . The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 2014; 26(12):2694-701. DOI: 10.1016/j.cellsig.2014.08.019. View

5.
Zhao F, Feng G, Zhu J, Su Z, Guo R, Liu J . 3-Methyladenine-enhanced susceptibility to sorafenib in hepatocellular carcinoma cells by inhibiting autophagy. Anticancer Drugs. 2021; 32(4):386-393. PMC: 7952045. DOI: 10.1097/CAD.0000000000001032. View